S90652 in Paediatric Hypertension

Phase 2

Completed

• Conditions: Hypertension

• Registration Number: NCT00202553
• Lead Sponsor: Institut de Recherches Internationales Servier

Brief Summary

The aim of the study is to assess the acceptability, safety and pharmacokinetics and effects on blood pressure of a paediatric formulation of perindopril given in hypertensive children

Detailed Description

Not available

Study Timeline

• Study Start: 2003-07
• Study First Submitted: 2005-09-12
• Study First Submitted QC: 2005-09-12
• Study First Posted: 2005-09-20
• Study Completion: 2006-12
• Status Verified: 2018-04
• Last Update Submitted: 2018-04-10
• Last Update Posted: 2018-04-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Hypertensive children

Exclusion Criteria

• Renal failure
• Unstable renal function
• Hyperkaliemia

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Safety assessed from the patient's (parents) complaints and the clinical follow-up

Secondary Outcome Measures

Name	Time	Method
Acceptability, efficacy, pharmacokinetics

Trial Locations

Locations (1)

Hôpital Necker Enfants Malades; 🇫🇷 Paris, France